|
|
Recent Articles
-
Eli Lilly’s Shares Have More Than Doubled During the Past 52 Weeks
Feb 11, 2024
-
Image: Eli Lilly’s shares have been on a tear these past few years.
On February 6, Eli Lilly reported excellent fourth-quarter results that showed revenue and non-GAAP earnings per share coming in better than expectations. The company’s fourth-quarter results were bolstered by sales of diabetes and weight-loss drug Mounjaro, which saw sales in the quarter leap to ~$2.2 billion from ~$279 million in the year ago period. We continue to be in awe of the sales momentum behind GLP-1 receptor agonists, and the opportunity continues to be robust, despite already rapid sales acceleration. Though Eli Lilly trades at a premium to the high end of our fair value estimate range, we may be low in our expectations of the company’s ability to tap this lucrative market in the longer run, and shares may still be attractive to the risk-seeking aggressive growth investor.
-
Earnings Roundup: PEP, DIS, ARM, PM
Feb 9, 2024
-
Image Source: Arm Holdings.
Pepsi issued an outlook for 2024 that came in lower than what the Street was expecting, but we like the diversification of having a strong brand entity such as Pepsi in the Best Ideas Newsletter portfolio. Disney is working hard to get back on track, and cost-cutting efforts have significantly helped its free cash flow generation. The firm is buying back stock, too, and recently upped its semi-annual dividend payout by 50%. Arm Holdings plc surprised the market in a big way, sending shares almost 50% higher following the report. The company's lucrative royalty business model and attractive exposure to artificial intelligence has investors extremely excited. Philip Morris is targeting strong organic revenue growth in 2024 thanks in part to Zyn growth, and we like the strong foundation that its free cash flow provides in supporting its dividend.
-
Dividend Increases/Decreases for the Week of February 9
Feb 9, 2024
-
Let's take a look at firms raising/lowering their dividends this week.
-
Chipotle Rallies, Long-term Outlook Remains Promising
Feb 7, 2024
-
Image Source: Valuentum.
We’re huge fans of Chipotle’s long-term growth runway, and we think the continued rollout of Chipotlanes offers the firm the ability to expand into the valuable breakfast daypart, which we think will come eventually. Its digital initiatives continue to work out well, too, with digital sales accounting for 36.1% of its total food and beverage revenue in the fourth quarter. Looking out to all of 2024, Chipotle expects full-year comparable restaurant sales growth in the mid-single-digit range and to add 285-315 new restaurants. The high end of our fair value estimate of Chipotle stands at $3,022 per share, and we continue to like shares in the Best Ideas Newsletter portfolio.
|
